- Home
- DALN vs FEMY Comparison
DALN vs FEMY Comparison
Compare DALN & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DALN
- FEMY
- Stock Information
- Founded
- DALN 1954
- FEMY 2004
- Country
- DALN United States
- FEMY United States
- Employees
- DALN N/A
- FEMY N/A
- Industry
- DALN Newspapers/Magazines
- FEMY Medical/Dental Instruments
- Sector
- DALN Consumer Discretionary
- FEMY Health Care
- Exchange
- DALN Nasdaq
- FEMY Nasdaq
- Market Cap
- DALN 33.9M
- FEMY 36.4M
- IPO Year
- DALN 2008
- FEMY 2021
- Fundamental
- Price
- DALN $6.20
- FEMY $1.64
- Analyst Decision
- DALN
- FEMY Strong Buy
- Analyst Count
- DALN 0
- FEMY 3
- Target Price
- DALN N/A
- FEMY $10.00
- AVG Volume (30 Days)
- DALN 41.5K
- FEMY 528.7K
- Earning Date
- DALN 03-05-2025
- FEMY 03-27-2025
- Dividend Yield
- DALN N/A
- FEMY N/A
- EPS Growth
- DALN N/A
- FEMY N/A
- EPS
- DALN N/A
- FEMY N/A
- Revenue
- DALN $128,286,000.00
- FEMY $1,260,643.00
- Revenue This Year
- DALN N/A
- FEMY $155.32
- Revenue Next Year
- DALN N/A
- FEMY $287.25
- P/E Ratio
- DALN N/A
- FEMY N/A
- Revenue Growth
- DALN N/A
- FEMY 15.33
- 52 Week Low
- DALN $2.98
- FEMY $0.86
- 52 Week High
- DALN $7.86
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- DALN 44.32
- FEMY 70.42
- Support Level
- DALN $5.84
- FEMY $1.57
- Resistance Level
- DALN $6.65
- FEMY $1.34
- Average True Range (ATR)
- DALN 0.41
- FEMY 0.14
- MACD
- DALN -0.03
- FEMY 0.05
- Stochastic Oscillator
- DALN 28.52
- FEMY 77.46
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.